NCT00985790View on ClinicalTrials.gov

Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children

PHASE2CompletedINTERVENTIONAL

Enrollment

599

Participants

Timeline

Start Date

October 8, 2009

Primary Completion Date

May 21, 2010

Study Completion Date

May 21, 2010

Conditions

Influenza

Interventions

BIOLOGICAL

Influenza vaccine GSK2321138A

Intramuscular injection

BIOLOGICAL

Fluarix™

Intramuscular injection

Trial Locations (2)

55075

GSK Investigational Site, Ecatepec de Morelos

04530

GSK Investigational Site, Mexico City

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00985790 - Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children | Biotech Hunter | Biotech Hunter